Therefore, for patients, the capacity of AML cells to survive increases in reactive aldehydes is associated with a poor prognosis and disease progression, and can be traced, at least in part, to increased expression of ALDH enzymes [105,106,107,108]. The gene discussed is LDHA; the disease is acute myeloid leukemia.